Smart Syringes Market by Product Type (Active Safety Syringes, Passive Safety Syringes, and Auto Disable Syringes), Age Group (Adults and Pediatrics), Application (Vaccination, Drug Delivery, and Blood Specimen Collection), and End User (Hospitals & HMOs, Family Practices, Diabetic Patients, Psychiatrics, and Others): Global Opportunity Analysis and Industry Forecast, 2020 – 2030

Market Definition:

At an estimated value of over USD 6.78 billion in 2019, the Global Smart Syringes Market is predicted to thrive at a CAGR of 7.9%and valued at over USD 15.65 billion over the forecast year 2020-2030.

Smart syringes are medical devices designed with safety mechanisms to avoid the reuse of syringes and regulate the unsafe injection practices. These syringes are equipped with its own read/write chip containing preset parameters, ranges, and usage tracking. It also prevents needlestick injuries to the patient and helps in minimizing transmission of blood-borne diseases such as hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). These syringes are used in various applications including drug delivery, vaccination, and blood specimen collection. There are different types of smart syringes such as passive safety syringes, auto disable (AD) syringes, and active safety syringes that are used according to the application. For the activation of the safety feature, the passive safety syringes usually retract automatically after the use, while active safety needles require manual activation. On the other hand, auto-disable (AD) syringes automatically get disabled after one use.

Market Dynamics and Trends:

Various factors such as increasing need to avoid needle stick injuries, high rate of blood-borne disease transmission such as hepatitis B, C, and HIV through inappropriate injection practices, and technological investments drive the smart syringes market growth. In addition, growing geriatric population, increase in the number of vaccination programs, and the need for preventing hospital or clinic-acquired infections significantly contribute to the growth of smart syringes market. However, low awareness among developing nations and high cost of smart syringes is expected to hamper market growth during forecast period. On the contrary, upsurge in the demand for auto-disabled (AD) syringes is expected to be opportunistic for the smart syringes market growth in the forecast period.

Market Segmentations and Scope of the Study:

The global Smart Syringes market share is segmented on the basis of product type, age group, application, end user, and geography. On the basis of product type, the market is segmented into active safety syringes, passive safety syringes, and auto disable syringes. On the basis of age group, the market is segmented into adults and pediatrics. By application, the market is divided into vaccination, drug delivery, and blood specimen collection. On the basis of end user, the market is segmented into hospitals & HMOs, family practices, diabetic patients, psychiatrics, and others. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.

Geographical Analysis:

In terms of geography, North America held major share of the smart syringes market in 2019. This is due to the extensive adoption of safety syringes in this region due to increasing awareness related with needle stick injuries. Also, constant improvements across healthcare practices in the region fuels the market growth. However, Asia-pacific is expected to grow rapidly with increasing market size. This is attributed to the increased healthcare expenses owing to the growing disposable income in developing countries across the region.

Competitive Landscape:

Maximum growth opportunities make the Smart Syringes market highly competitive. Some of the major players in the market are Smiths Group Plc, Baxter International Inc., B. Braun Melsungen AG, Terumo Medical Corp., Unilife Corp., Revolutions Medical Corp., Retractable Technologies Inc, Medtronic Plc (Covidien), Becton, Dickinson and Company., and many more. A number of developmental strategies have been adopted by companies in the past few years.

For instance, in December 2020, BD (Becton, Dickinson and Company) planned to invest about $1.2 billion over a 4-year period to expand as well as add a new manufacturing facility in Europe and to upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six global manufacturing locations. In May 2020, Baxter International Inc. announced the approval of CE marking and regulatory from Therapeutic Goods Administration (TGA), Australia for the Evo IQ Syringe Infusion System.

KEY BENEFITS:

• The smart syringes market report provides the quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on.

• The study comprises an extensive analysis of the Smart Syringes market trend including the current and future trends for depicting the prevalent investment pockets in the market

• The information related to key drivers, restraints and opportunities and their impact on the smart syringes market is provided in the report.

• The market share of the players in the global Smart Syringes market along with their competitive analysis.

• Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.

KEY MARKET SEGMENTS:

By Product Type

• Active Safety Syringes

• Passive Safety Syringes

• Auto Disable Syringes

By Age Group

• Adults

• Pediatrics

By Application

• Vaccination

• Drug Delivery

• Blood Specimen Collection

By End User

• Hospitals & HMOs

• Family Practices

• Diabetic Patients

• Psychiatrics

• Others

By Geography

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

• Asia-Pacific

  • China

  • India

  • Japan

  • Rest of Asia-Pacific

• Rest of World

  • Brazil

  • Saudi Arabia

  • South Africa

  • Remaining Countries

REPORT SCOPE AND SEGMENTATION:

Test